194 related articles for article (PubMed ID: 12900437)
21. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms.
Bartels NK; Börgel J; Wieczorek S; Büchner N; Hanefeld C; Bulut D; Mügge A; Rump LC; Sanner BM; Epplen JT
BMC Med; 2007 Jan; 5():1. PubMed ID: 17198546
[TBL] [Abstract][Full Text] [Related]
23. β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals.
Thomsen M; Dahl M; Tybjærg-Hansen A; Nordestgaard BG
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1074-9. PubMed ID: 22466342
[TBL] [Abstract][Full Text] [Related]
24. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
25. Association of beta 2 adrenoceptor gene polymorphisms in Malaysian hypertensive subjects.
Komara M; Vasudevan R; Ismail P; Bakar SA; Pishva SR; Heidari F
Genet Mol Res; 2014 Apr; 13(2):2939-48. PubMed ID: 24782128
[TBL] [Abstract][Full Text] [Related]
26. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus.
Ishiyama-Shigemoto S; Yamada K; Yuan X; Ichikawa F; Nonaka K
Diabetologia; 1999 Jan; 42(1):98-101. PubMed ID: 10027586
[TBL] [Abstract][Full Text] [Related]
27. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes.
Bengtsson K; Orho-Melander M; Melander O; Lindblad U; Ranstam J; Råstam L; Groop L
Hypertension; 2001 May; 37(5):1303-8. PubMed ID: 11358945
[TBL] [Abstract][Full Text] [Related]
28. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
[TBL] [Abstract][Full Text] [Related]
29. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.
Eisenach JH; McGuire AM; Schwingler RM; Turner ST; Joyner MJ
Physiol Genomics; 2004 Feb; 16(3):323-8. PubMed ID: 14665698
[TBL] [Abstract][Full Text] [Related]
30. Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects.
Gjesing AP; Andersen G; Burgdorf KS; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Diabetologia; 2007 Mar; 50(3):563-8. PubMed ID: 17221209
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men.
Rosmond R; Ukkola O; Chagnon M; Bouchard C; Björntorp P
J Intern Med; 2000 Sep; 248(3):239-44. PubMed ID: 10971791
[TBL] [Abstract][Full Text] [Related]
32. Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan.
Chou YC; Tsai CN; Lee YS; Pei JS
Pediatr Int; 2012 Feb; 54(1):111-6. PubMed ID: 22115535
[TBL] [Abstract][Full Text] [Related]
33. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.
Petrone A; Zavarella S; Iacobellis G; Zampetti S; Vania A; Di Pietro S; Galgani A; Leonetti F; Di Mario U; Buzzetti R
Eur J Hum Genet; 2006 Jan; 14(1):94-100. PubMed ID: 16251889
[TBL] [Abstract][Full Text] [Related]
34. [Polymorphisms in the beta2 and beta3 adrenergic receptor genes in obstructive sleep apnea/hypopnea syndrome].
Zhang LQ; Yao WZ; He QY; Wang YZ; Ren B; Lin YP
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):333-6. PubMed ID: 16009000
[TBL] [Abstract][Full Text] [Related]
35. Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol.
Corbalán MS; Marti A; Forga L; Martínez-González MA; Martínez JA
Eur J Nutr; 2002 Jun; 41(3):114-8. PubMed ID: 12111048
[TBL] [Abstract][Full Text] [Related]
36. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure.
Pereira AC; Sposito AC; Mota GF; Cunha RS; Herkenhoff FL; Mill JG; Krieger JE
Atherosclerosis; 2006 Jan; 184(1):193-200. PubMed ID: 15916766
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor β2 surface gene on obesity and metabolic phenotypes in Taiwan.
Hsiao TJ; Lin E
J Investig Med; 2014 Feb; 62(2):310-5. PubMed ID: 24322328
[TBL] [Abstract][Full Text] [Related]
38. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
Büscher R; Eilmes KJ; Grasemann H; Torres B; Knauer N; Sroka K; Insel PA; Ratjen F
Pharmacogenetics; 2002 Jul; 12(5):347-53. PubMed ID: 12142724
[TBL] [Abstract][Full Text] [Related]
39. beta2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation.
Kaymak C; Kocabaş NA; Durmaz E; Oztuna D
Int J Toxicol; 2006; 25(6):443-9. PubMed ID: 17132602
[TBL] [Abstract][Full Text] [Related]
40. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
